These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 22936682)
1. Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: yes. Havrdová E Mult Scler; 2012 Sep; 18(9):1209-10. PubMed ID: 22936682 [No Abstract] [Full Text] [Related]
2. Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: no. Weinshenker BG Mult Scler; 2012 Sep; 18(9):1211-2. PubMed ID: 22936683 [No Abstract] [Full Text] [Related]
3. Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: commentary. Hutchinson M Mult Scler; 2012 Sep; 18(9):1213-4. PubMed ID: 22936684 [No Abstract] [Full Text] [Related]
4. The urge to prove and its ills. Yazici H Bull Hosp Jt Dis (2013); 2013; 71(2):121-3. PubMed ID: 24032611 [TBL] [Abstract][Full Text] [Related]
5. Alliance to bolster translation of academic R&D assets. Allison M Nat Biotechnol; 2013 Apr; 31(4):275. PubMed ID: 23563411 [No Abstract] [Full Text] [Related]
6. Biomedical institute opens its doors to physicists. Gibney E Nature; 2014 May; 509(7502):544-5. PubMed ID: 24870523 [No Abstract] [Full Text] [Related]
7. Outlook: finding improved medicines: the role of academic-industrial collaboration. Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439 [TBL] [Abstract][Full Text] [Related]
12. Drug industry in "depression". Almog DM Med Sci Monit; 2005 Jan; 11(1):SR1-4. PubMed ID: 15614206 [TBL] [Abstract][Full Text] [Related]
13. We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: yes. Scolding N Mult Scler; 2012 Jun; 18(6):782-3. PubMed ID: 22619225 [TBL] [Abstract][Full Text] [Related]
14. Addressing the regulatory and scientific challenges in multiple sclerosis--a statement from the EU regulators. Balabanov P; Haas M; Elferink A; Bakchine S; Broich K Mult Scler; 2014 Sep; 20(10):1282-7. PubMed ID: 25160121 [TBL] [Abstract][Full Text] [Related]
15. The new Silk Road. Chien K; Chien L Nature; 2004 Mar; 428(6979):208-9. PubMed ID: 15014508 [No Abstract] [Full Text] [Related]
16. From academic solos to industrial symphonies. Acton G; Gómez-Yafal A; Walsh E Nat Biotechnol; 2012 Jul; 30(7):585-7. PubMed ID: 22781674 [No Abstract] [Full Text] [Related]
17. Externalizing research through adaptive frameworks. Vedel JB; Irwin A; Andersen PH Nat Rev Drug Discov; 2013 Oct; 12(10):723-4. PubMed ID: 24080683 [TBL] [Abstract][Full Text] [Related]
18. The academic research consortium governance charter. Krucoff MW; Mehran R; van Es GA; Boam AB; Cutlip DE JACC Cardiovasc Interv; 2011 May; 4(5):595-6. PubMed ID: 21596341 [No Abstract] [Full Text] [Related]
19. Partnering between pharma peers on the rise. Mullard A Nat Rev Drug Discov; 2011 Aug; 10(8):561-2. PubMed ID: 21804581 [No Abstract] [Full Text] [Related]
20. Growth industry. Lewis R Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202 [No Abstract] [Full Text] [Related] [Next] [New Search]